Phosphoproteomics-Based Characterization of Prostaglandin E2 Signaling in T Cells
Author(s) -
Anna Mari Lone,
Kjetil Taskén
Publication year - 2021
Publication title -
molecular pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.469
H-Index - 198
eISSN - 1521-0111
pISSN - 0026-895X
DOI - 10.1124/molpharm.120.000170
Subject(s) - phosphoproteomics , characterization (materials science) , prostaglandin , computational biology , microbiology and biotechnology , chemistry , biology , biochemistry , nanotechnology , materials science , phosphorylation , protein phosphorylation , protein kinase a
Prostaglandin E 2 (PGE 2 ) is a key lipid mediator in health and disease and serves as a crucial link between the immune response and cancer. With the advent of cancer therapies targeting PGE 2 signaling pathways at different levels, there has been increased interest in mapping and understanding the complex and interconnected signaling pathways arising from the four distinct PGE 2 receptors. Here, we review phosphoproteomics studies that have investigated different aspects of PGE 2 signaling in T cells. These studies have elucidated PGE 2 's regulatory effect on T cell receptor signaling and T cell function, the key role of protein kinase A in many PGE 2 signaling pathways, the temporal regulation of PGE 2 signaling, differences in PGE 2 signaling between different T cell subtypes, and finally, the crosstalk between PGE 2 signaling pathways elicited by the four distinct PGE2 receptors present in T cells. SIGNIFICANCE STATEMENT: Through the reviewed studies, we now have a much better understanding of PGE 2 's signaling mechanisms and functional roles in T cells, as well as a solid platform for targeted and functional studies of specific PGE 2 -triggered pathways in T cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom